Holistic Planning’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$980K Sell
40,712
-1,403
-3% -$36.7K 0.15% 135
2026
Q1
$1.18M Sell
42,115
-3,464
-8% -$92.2K 0.24% 91
2025
Q4
$1.13M Sell
45,579
-4,211
-8% -$106K 0.24% 87
2025
Q3
$1.27M Sell
49,790
-2,634
-5% -$65K 0.33% 61
2025
Q2
$1.27M Buy
52,424
+1,180
+2% +$27.5K 0.36% 53
2025
Q1
$1.3M Sell
51,244
-329
-0.6% -$8.61K 0.44% 44
2024
Q4
$1.37M Buy
51,573
+5,209
+11% +$141K 0.5% 39
2024
Q3
$1.34M Buy
46,364
+31,681
+216% +$924K 0.57% 37
2024
Q2
$407K Hold
14,683
0.31% 71
2024
Q1
$407K Sell
14,683
-1,167
-7% -$32.4K 0.31% 71
2023
Q4
$456K Buy
+15,850
New +$479K 0.38% 63

Other funds holding PFE

Holistic Planning's PFE Position: Q2 2026 in Review

Holistic Planning reduced its Pfizer (PFE) stake by 3.3% in Q2 2026, selling an estimated $36.7K and leaving 40,712 shares worth $980K. The position accounts for 0.15% of the portfolio, ranked #135.

Holistic Planning first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.37M in Q4 2024. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Holistic Planning held 40,712 shares of Pfizer worth $980K as of Q2 2026.
  • Holistic Planning sold 1,403 Pfizer shares in Q2 2026, an estimated $36.7K.
  • Pfizer made up 0.15% of Holistic Planning's portfolio in Q2 2026, its #135 holding.
  • Holistic Planning first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Holistic Planning's Pfizer position peaked at $1.37M in Q4 2024.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Holistic Planning's 13F filing for Q2 2026, filed 10 Aug 2026.